Renier Brentjens
RB
Co-founder
路 Buffalo, United States
Renier Brentjens
Co-founder
About
Co-founder of Juno Therapeutics. Pioneer of CAR-T cell immunotherapy, first to publish efficacy in adult acute lymphoblastic leukemia. Spent 20+ years at Memorial Sloan Kettering. Winner of 2024 Warren Alpert Prize.
Score Breakdown
93Influence
40Track Record
91Visibility
2Profile
50Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
Who is Renier Brentjens?
Co-founder of Juno Therapeutics. Pioneer of CAR-T cell immunotherapy, first to publish efficacy in adult acute lymphoblastic leukemia. Spent 20+ years at Memorial Sloan Kettering. Winner of 2024 Warren Alpert Prize.
What is Renier Brentjens's current role?
Renier Brentjens is currently Co-founder.
Where is Renier Brentjens based?
Renier Brentjens is based in Buffalo, United States.
Contact Info
Similar People